{
    "2021-03-08": [
        [
            {
                "time": "2023-10-05",
                "original_text": "What Does Abbott's Debt Look Like?",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Debt"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Abbott Introduces NeuroSphere™ Virtual Clinic, First-of-its-Kind Remote Neuromodulation Patient-Care Technology in the U.S.",
                "features": {
                    "keywords": [
                        "Abbott",
                        "NeuroSphere",
                        "Virtual Clinic",
                        "Remote",
                        "Technology"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "The Zacks Analyst Blog Highlights: Abbott, Johnson & Johnson, Masimo Corp and Medtronic",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst Blog",
                        "Abbott",
                        "Johnson & Johnson",
                        "Masimo Corp",
                        "Medtronic"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Abbott’s Alinity m Resp-4-Plex Test Cleared For Emergency Use In US; Street Says Buy",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Alinity m",
                        "Resp-4-Plex",
                        "Test",
                        "Cleared",
                        "Emergency Use",
                        "Buy"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}